Transwell assays showed that CXCL13 could increase the migratory ability of ccRCC cells, and CXCR5 knockdown could reduce the pro-migration effect of CXCL13 on ccRCC cells (Figure 5E). This evidence concerns the gene CXCR5 and nonpapillary renal cell carcinoma.